Author(s): Barkhoudarian G, Whitelegge JP, Kelly DF, Simonian M
Abstract Share this page
Abstract The aim of this pilot study was to evaluate the use of advanced proteomics techniques to identify novel protein markers that contribute to the transformation of benign meningiomas to more aggressive and malignant subtypes. Multiplex peptide stable isotope dimethyl labelling and nano-LCMS was used to identify and quantify the differentially expressed proteins in WHO Grade I, II and III meningioma tissues. The proteins identified will help elucidate the process of transformation to malignancy and may contribute to improved diagnosis and treatment of these aggressive tumors.
This article was published in J Proteomics Bioinform
and referenced in Journal of Data Mining in Genomics & Proteomics